BR112013001962A2 - composição compreendendo goma-laca e/ou um sal desta e glicolato de amido sódico - Google Patents

composição compreendendo goma-laca e/ou um sal desta e glicolato de amido sódico

Info

Publication number
BR112013001962A2
BR112013001962A2 BR112013001962A BR112013001962A BR112013001962A2 BR 112013001962 A2 BR112013001962 A2 BR 112013001962A2 BR 112013001962 A BR112013001962 A BR 112013001962A BR 112013001962 A BR112013001962 A BR 112013001962A BR 112013001962 A2 BR112013001962 A2 BR 112013001962A2
Authority
BR
Brazil
Prior art keywords
shellac
salt
composition
sodium starch
starch glycolate
Prior art date
Application number
BR112013001962A
Other languages
English (en)
Other versions
BR112013001962B1 (pt
Inventor
Carlo De Angelis
Daniele Giovannone
Original Assignee
Gnosis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis Spa filed Critical Gnosis Spa
Publication of BR112013001962A2 publication Critical patent/BR112013001962A2/pt
Publication of BR112013001962B1 publication Critical patent/BR112013001962B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

composição compreendendo goma-laca e/ou um sal desta e glicolato de amido sódico. o objetivo da presente invenção é uma composição compreendendo goma-laca e/ou um sal desta e glicolato de amido sódico e pelo menos um excipiente fisiologicamente aceitável e um processo para obtê-la.
BR112013001962-0A 2010-07-26 2011-06-30 composição compreendendo goma-laca e/ou um sal desta e glicolato de amido sódico BR112013001962B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36772010P 2010-07-26 2010-07-26
US61/367,720 2010-07-26
ITMI2010A001386A IT1401146B1 (it) 2010-07-27 2010-07-27 Composizione comprendente shellac e/o un suo sale e sodio amido glicolato
ITMI2010A001386 2010-07-27
PCT/IB2011/052896 WO2012014104A2 (en) 2010-07-26 2011-06-30 Composition comprising shellac and/or a salt thereof and sodium starch glycolate

Publications (2)

Publication Number Publication Date
BR112013001962A2 true BR112013001962A2 (pt) 2016-05-24
BR112013001962B1 BR112013001962B1 (pt) 2021-07-06

Family

ID=43598463

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013001962-0A BR112013001962B1 (pt) 2010-07-26 2011-06-30 composição compreendendo goma-laca e/ou um sal desta e glicolato de amido sódico

Country Status (23)

Country Link
US (1) US9750815B2 (pt)
EP (1) EP2598122B1 (pt)
JP (1) JP5873868B2 (pt)
KR (1) KR101931638B1 (pt)
CN (1) CN103052381B (pt)
AU (1) AU2011284387B2 (pt)
BR (1) BR112013001962B1 (pt)
CA (1) CA2804715C (pt)
DK (1) DK2598122T3 (pt)
EA (1) EA025644B1 (pt)
ES (1) ES2553604T3 (pt)
GE (1) GEP20156363B (pt)
HR (1) HRP20151125T1 (pt)
HU (1) HUE026267T2 (pt)
IT (1) IT1401146B1 (pt)
MX (1) MX336929B (pt)
NZ (1) NZ606248A (pt)
PL (1) PL2598122T3 (pt)
PT (1) PT2598122E (pt)
RS (1) RS54305B1 (pt)
SG (1) SG186928A1 (pt)
SI (1) SI2598122T1 (pt)
WO (1) WO2012014104A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131906A1 (it) * 2013-11-18 2015-05-19 Gnosis Spa Composizioni solide orali a lento rilascio
US10553327B2 (en) * 2014-05-26 2020-02-04 Furukawa Electric Co., Ltd. Aluminum alloy conductor wire, aluminum alloy stranded wire, coated wire, wire harness and method of manufacturing aluminum alloy conductor wire

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8603957D0 (en) * 1986-02-18 1986-03-26 Ciba Geigy Ag Acylated quinone derivatives
CN1260172A (zh) 1998-12-18 2000-07-19 国家医药管理局上海医药工业研究院 右旋酮洛芬制剂
ES2295062T3 (es) * 1999-09-02 2008-04-16 Nostrum Pharmaceuticals, Inc. Formulacion granulada de liberacion sostenida.
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
IT1318597B1 (it) 2000-06-23 2003-08-27 A C R Applied Coating Res S A Uso di un amido ad alto contenuto di amilosio acetilato epregelatinizzato.
JP2005508331A (ja) * 2001-09-28 2005-03-31 サン・ファーマシューティカル・インダストリーズ・リミテッド 糖尿病の処置のための投与製剤
US20040103821A1 (en) * 2002-11-29 2004-06-03 Freund Industrial Co., Ltd. Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same
US20050031775A1 (en) 2003-08-07 2005-02-10 Charles Signorino High gloss film coating and stable solution therefor
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
CN101896170A (zh) * 2007-11-13 2010-11-24 赫尔克里士公司 用于营养品和药物剂型的水分散性肠溶衣配制物
DE102008063800A1 (de) * 2008-12-19 2010-06-24 Henkel Ag & Co. Kgaa Beschichtete Färbemittel
WO2010075290A1 (en) 2008-12-22 2010-07-01 President And Fellows Of Harvard College Unsaturated heterocyclic inhibitors of necroptosis
CA2772760A1 (en) 2008-12-23 2010-07-01 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
WO2010080977A2 (en) 2009-01-09 2010-07-15 Cenerx Biopharma, Inc. Oral sustained release antidepressant formulation
WO2010132072A1 (en) 2009-05-15 2010-11-18 Neuraxon, Inc Treatment or prevention of migraine by dosing at aura
WO2011026240A1 (en) 2009-09-04 2011-03-10 Zalicus Pharmaceuticals Ltd. Oxopiperazine derivatives for the treatment of pain and epilepsy

Also Published As

Publication number Publication date
KR101931638B1 (ko) 2018-12-24
SG186928A1 (en) 2013-02-28
HUE026267T2 (en) 2016-06-28
MX336929B (es) 2016-02-05
EP2598122B1 (en) 2015-09-16
RS54305B1 (en) 2016-02-29
WO2012014104A2 (en) 2012-02-02
BR112013001962B1 (pt) 2021-07-06
SI2598122T1 (sl) 2015-12-31
NZ606248A (en) 2015-02-27
PT2598122E (pt) 2015-12-07
MX2013001061A (es) 2013-03-20
ITMI20101386A1 (it) 2012-01-28
HRP20151125T1 (hr) 2015-11-20
JP2013532679A (ja) 2013-08-19
GEP20156363B (en) 2015-09-10
EA201370024A1 (ru) 2013-06-28
CA2804715A1 (en) 2012-02-02
CA2804715C (en) 2017-12-19
KR20130041133A (ko) 2013-04-24
US9750815B2 (en) 2017-09-05
EP2598122A2 (en) 2013-06-05
EA025644B1 (ru) 2017-01-30
ES2553604T3 (es) 2015-12-10
CN103052381A (zh) 2013-04-17
CN103052381B (zh) 2015-04-01
AU2011284387B2 (en) 2016-08-04
IT1401146B1 (it) 2013-07-12
AU2011284387A2 (en) 2013-03-07
DK2598122T3 (da) 2015-10-19
US20130133551A1 (en) 2013-05-30
AU2011284387A1 (en) 2013-02-07
WO2012014104A3 (en) 2012-06-07
JP5873868B2 (ja) 2016-03-01
PL2598122T3 (pl) 2016-02-29

Similar Documents

Publication Publication Date Title
BR112013031794A2 (pt) novos derivados de oxintomodulina e composição farmacêutica para o tratamento da obesidade compreendendo os mesmos
BR112019012062A2 (pt) tratamento de uma doença do trato gastrointestinal com um inibidor de jak e dispositivos
BR112015014253A2 (pt) produtos de higiene bucal que compreendem um complexo de haleto de aminoácido e zinco tetrabásico
GT201300186A (es) Composiciones farmacéuticas que comprenden anticuerpos humanos frente a pcsk9
ZA201401815B (en) Tibial orthopaedic surgical instruments for setting offset
BR112013028281A2 (pt) compostos e composições para inibição de nampt
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
CO6650346A2 (es) Composiciones de tetraciclina
CY1115736T1 (el) Νεες συνθεσεις για αντιμετωπιση cmt και σχετικων διαταραχων
BR112015027079A2 (pt) composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa, sal antitranspirante e método para a obtenção de um benefício antitranspirante
IN2014DN10670A (pt)
BR112014005025A2 (pt) composição farmacêutica para uso no tratamento de uma doença neurodegenerativa
BR112014014939A2 (pt) composição de tratamento de sementes
BR112015028096A2 (pt) forma cristalina de um hidrato, processo para a preparação da forma cristalina, composição farmacêutica, forma cristalina, combinação farmacêutica, hidrato cristalino e cristais
BR112013029730A2 (pt) composição farmacêutica de rosuvastatina cálcica
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
BR112012023836A2 (pt) composto tricíclicos e inibidores de pbk contendo os mesmos
BR112015002275A2 (pt) processos e intermediários para a preparação de inibidores da integrase
BR112015027333A2 (pt) composição aquosa, método para a obtenção de um benefício antitranspirante, método para a fabricação de uma composição antitranspirante aquosa e utilização de uma composição
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria
BRPI1008277A2 (pt) composição de cloreto de sódio, processo para a preparação de uma composição de cloreto de sódio e uso de uma composição de cloreto de sódio não aglomerante
BR112018001451A2 (pt) compostos úteis para a inibição de ror-gama-t
MX2013008699A (es) Compuestos para reducir la produccion de beta-amiloide.
BR112015011515A2 (pt) Composições farmacêuticas de inibidores de cetp

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/06/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.